GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32985
Submission : 2018-07-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32986
Submission : 2018-07-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33114
Submission : 2018-09-18
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32985
Submission : 2018-07-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32986
Submission : 2018-07-11
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33114
Submission : 2018-09-18
Status : Active
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : PLAVIX
Dosage Form : TABLET; ORAL
Application Number : 20839
Country : US
Patented : No
Drug : K-TAB
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18279
Country : US
Patented : No
Drug : BIAXIN XL
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 50775
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50698
Country : US
Patented : No
Drug : BIAXIN
Dosage Form : TABLET; ORAL
Application Number : 50662
Country : US
Patented : No
Drug : HYDROXYPROGESTERONE CAPROATE
Dosage Form : SOLUTION; INTRAMUSCULAR
Application Number : 200271
Country : US
Patented : No
Drug : ESTRADIOL VALERATE
Dosage Form : INJECTABLE; INJECTION
Application Number : 90920
Country : US
Patented : No
Drug : FASLODEX
Dosage Form : SOLUTION; INTRAMUSCULAR
Application Number : 21344
Country : US
Patented : No
Drug : FULVESTRANT
Dosage Form : SOLUTION; INTRAMUSCULAR
Application Number : 208811
Country : US
Patented : No
Drug : CARDIZEM CD
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20062
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
21 Dec 2024
Reply
28 Oct 2022
Reply
16 Jun 2020
Reply
18 Jan 2020
Reply
17 Oct 2019